Scheduled Maintenance Notice

Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.

Select Publications

Journal articles

Neuhaus J; Jacobs DR; Baker JV; Calmy A; Duprez D; La Rosa A; Kuller LH; Pett SL; Ristola M; Ross M; Shlipak MG; Tracy R; Neaton JD, 2010, 'Markers of inflammation, coagulation and renal function are elevated in adults with HIV infection', Journal of Infectious Diseases, 201, pp. 1788 - 1795

Pett SL; Kelleher AD; Emery S, 2010, 'Role of interleukin-2 inpatients with HIV infection', Drugs, 70, pp. 1115 - 1130

Pett SL; Mccarthy M; Cooper DA; MacRae K; Tendolkar A; Norris R; Strizki J; Williams KM; Emery S, 2009, 'A Phase I study to explore the activity and safety of SCH532706, a small molecule chemokine receptor-5 antagonist in HIV type-1-infected patients', Antiviral Therapy, 14, pp. 111 - 115

Zaunders J; Munier ML; Seddiki N; Pett SL; Ip S; Bailey M; Xu Y; Brown KJ; Dyer W; Kim MS; De Rose R; Kent SJ; Jiang L; Breit SN; Emery S; Cunningham AL; Cooper DA; Kelleher AD, 2009, 'High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40)', Journal of Immunology, 183, pp. 2827 - 2836, http://dx.doi.org/10.4049/jimmunol.0803548

Pett SL, 2009, 'Immunotherapies in HIV-1 infection', Current opinion in HIV & AIDS, 4, pp. 188 - 193

Seddiki N; Sasson SC; Santner-Nanan B; Munier M; Van Bockel DJ; Ip S; Marriott D; Pett SL; Nanan R; Cooper DA; Zaunders J; Kelleher AD, 2009, 'Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease', European Journal of Immunology, 39, pp. 391 - 403, http://dx.doi.org/10.1002/eji.200838630

Pett SL; Zaunders J; Bailey M; Cooper DA; MacRae K; Emery S; Kelleher A, 2008, 'Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy', Journal of the International AIDS Society, 11, http://dx.doi.org/10.1186/1758-2652-11-s1-p297

Boyd MA; Pett SL, 2008, 'Experimental and clinical pharmacology - HIV fusion inhibitors: a review', Australian Prescriber, 31, pp. 66 - 69

Dyer W; Pett SL; Sullivan JS; Emery S; Cooper DA; Kelleher AD; Lloyd AR; Lewin S, 2007, 'Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples', Clinical and Vaccine Immunology, 14, pp. 52 - 59

Lifson AR; Rhame FS; Belloso WH; Dragsted UB; El-Sadr WM; Gatell JM; Hoy JF; Krum EA; Nelson R; Pedersen C; Pett SL; Davey RT; Neaton J; Abrams D; Cahn P; Clotet B; Cooper D; Darbyshire J; Sandra L; Emery S; Hengge U; Lane HC; Lange J; Levy G; Levy Y; Lundgren J; Mitsuyasu R; Routy JP; Tambussi G, 2006, 'Reporting and evaluaton of HIV-related clinical endpoints in two multicenter international clinical trials', HIV Clinical Trials, 7, pp. 125 - 141, http://dx.doi.org/10.1310/7MER-XFA7-1762-E2WR

Group* ER; Group: W; Pett SL; Wand H; Law MG; Arduino R; Lopez JC; Knysz B; Pereira LC; Pollack S; Reiss P; Tambussi G, 2006, 'Evaluation of Subcutaneous Proleukin (Interleukin-2) in a Randomized International Trial (ESPRIT): Geographical and Gender Differences in the Baseline Characteristics of Participants', HIV Research & Clinical Practice, 7, pp. 70 - 85, http://dx.doi.org/10.1310/hct.2006.7.2.005

Pett SL; Wand H; Law MG; Arduino R; Lopez JC; Knysz B; Pereira LC; Pollack S; Reiss P; Tambussi G; Abrams DI; Cooper DA; Darbyshire JH; Duncan WR; Emery S; Clifford Lane H; Lehrman S; Lundgren JD; Neaton JD; Aguilar L; Angel EB; Aquilia S; Belloso W; Benetucci J; Bittar V; Cahn P; Casiro A; Contarelli J; Corral J; Daciuk L; David D; Ines F; Fridman D; Galache V; Guaragna G; Ivalo S; Laplume H; Lasala MB; Lattes R; Lasovsky J; Lopardo G; Losso M; Lourtau L; Lupo S; Maranzana A; Marson C; Massera L; del Lujan Sanchez M; Somenzini C; Tocci M; Algar S; Anderson J; Austin D; Baker D; Blavius K; Bloch M; Boyle M; Bradford D; Carrall L; Carr A; Chuah J; Curry M; D'Arcy-Evans C; Dobson P; Doong N; Ferguson W; Finlayson R; French M; Gold J; Habel P; Hoy J; Hudson J; James R; Jeganathan S; Leung J; Lowe K; MacRae K; Mallal S; McMurchie M; Medland N; Mijch A; Miller S; Murray J; Orth D; Patching J; Primrose R; Quan D; Rawlinson M; Ree H; Richardson R; Rogers G; Roney J; Roth N; Shaw D; Soo TM; Sowden D; Street A; Street A; Vale R, 2006, 'Evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants', HIV Clinical Trials, 7, pp. 70 - 85, http://dx.doi.org/10.1310/4733-ACQF-F3P4-2QAC

Stark D; Pett SL; Marriott D; Harkness JL, 2006, 'Post-kala-azar dermal leishmaniasis due to Leishmania infantum in a human immunodeficiency virus type 1-infected patient', Journal of Clinical Microbiology, 44, pp. 1178 - 1180

Samaras K; Pett SL; Gowers A; McMurchie M; Cooper DA, 2005, 'Iatrogenic Cushing`s syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: Six cases', Journal of Clinical Endocrinology and Metabolism, 90, pp. 4394 - 4398

Pett SL; Kelleher A, 2004, 'Antiretroviral therapy-induced immune restoration in HIV infection: A double-edged sword?', Expert Review of Anti Infective Therapy, 2, pp. 335 - 339, http://dx.doi.org/10.1586/14787210.2.3.335

Pett SL; Williams LA; Day RO; Lloyd AR; Carr AD; Clezy KR; Emery S; Kaplan E; Mcphee D; Mclachlan AJ; Gelder F; Lewin S; Liauw WS; Williams KM, 2004, 'A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals', HIV Clinical Trials, 5, pp. 91 - 98

Pett SL; Kelleher AD, 2003, 'Cytokine therapies in HIV-1 infection: Present and future', Expert Review of Anti Infective Therapy, 1, pp. 83 - 96, http://dx.doi.org/10.1586/14787210.1.1.83

Pett SL; Kelleher AD, 2003, 'Cytokine therapies in HIV-1 infection: present and future', Expert Review of Anti-Infective Therapy, 1, pp. 89 - 102

O Loughlin AJ; Pett SL; Anderson D; Yorke J; Chua R; Williams DB; Hayward CS; Keogh AM; Macdonald PS; Cunningham PH, 2003, 'Cytomegalovirus polymerase chain reaction tests can replace endoscopy and biopsy for the initial diagnosis of cytomegalovrius gastrointestinal disease in patients following heart transplantation', CSANZ

Pett SL; Dore GJ; Fielden R; Cooper DA, 2002, 'Cyclical hepatitis and early liver cirrhosis after hepatitis C seroconversion during pulsed antiretroviral therapy for primary HIV-1', AIDS, 16, pp. 2364 - 2365

Emery S; Abrams D; Cooper DA; Darbyshire JH; Lane HC; Lundgren JD; Neaton JD, 2002, 'The evaluation of subcutaneous proleukin® (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT. Control Clin Trials', Control Clin Trials, 23, pp. 198 - 220

Pett SL; Emery S, 2001, 'Immunomodulators as adjunctive therapy for HIV-1 infection', Journal of Clinical Virology, 22, pp. 289 - 295, http://dx.doi.org/10.1016/S1386-6532(01)00201-3

Suzuki K; Cunningham P; Harris C; Leas L; Zaunders J; Cooper DA; Kaufmann GR; Pett SL; Kelleher A; Mukaide M; Imai M; Kondo M; Finlayson R, 2001, 'Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine', AIDS Research and Human Retroviruses, 17, pp. 1293 - 1296, http://dx.doi.org/10.1089/088922201750461366

Pett SL; Milliken S, 2000, 'Current review of the metabolic and endocrine disturbances in human immunodeficiency virus infection', Current Opinion in Endocrinology and Diabetes, 7, pp. 96 - 101, http://dx.doi.org/10.1097/00060793-200004000-00009

Pett SL; Milliken S, 2000, 'Current review of the metabolic and endocrine disturbances in human immunodeficiency virus infection', Current Opinion in Endocrinology & Diabetes, 7, pp. 96 - 101, http://dx.doi.org/10.1097/00075197-200004000-00009

Akbar AN; Borthwick N; Salmon M; Gombert W; Bofill M; Shamsadeen N; Pilling D; Pett S; Grundy JE; Janossy G, 1993, 'The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory.', Journal of Experimental Medicine, 178, pp. 427 - 438, http://dx.doi.org/10.1084/jem.178.2.427

Dwyer DE; Lynfield R; Losso MH; Davey RT; Cozzi-Lepri A; Wentworth D; Uyeki TM; Gordin F; Angus B; Qvist T; Emery S; Lundgren J; Neaton JD, 'Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009-2015', OPEN FORUM INFECTIOUS DISEASES, 4, http://dx.doi.org/10.1093/ofid/ofx212


Back to profile page